Peter Ihnat

Peter Ihnat is the Director of Protein Biochemistry at Regeneron Pharmaceuticals, Inc., where they focus on molecular profiling and development risk assessment of therapeutic proteins. Previously, Peter held positions as a Senior Principal Scientist at Bristol-Myers Squibb and as a Principal Scientist at Schering-Plough Research Institute. Peter's extensive education includes ongoing studies for a PhD in Pharmaceutics at the University of Nebraska Medical Center, alongside a BA in Biochemistry from Rutgers University and a BS in Pharmacy from Albany College of Pharmacy of Union University. They have demonstrated leadership in aligning scientific research with business objectives and possess a strong technical insight into pharmaceutical products.